UroViu

Executive Summary

UroViu Corporation is a privately held medical device company based in San Jose, California, founded in 2015. The company specializes in single-use endoscopy, developing portable, on-demand platforms for cystoscopy and hysteroscopy procedures. By eliminating the need for scope reprocessing, UroViu's technology aims to reduce infection risk, improve patient outcomes, and enhance clinical workflow efficiency. While the company has not disclosed total funding or valuation, its focus on single-use devices addresses a growing demand in urology and gynecology for safer, more convenient diagnostic and therapeutic tools. The market for disposable endoscopes is expanding due to infection control concerns and the need for cost-effective, point-of-care solutions. UroViu's products, if successfully commercialized, could capture share in the multi-billion-dollar endoscopy market.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for next-generation cystoscope70% success
• Q4 2026Series B funding round to support commercial launch60% success
• Q2 2026Strategic partnership with a urology group for clinical validation50% success